Leaflet CLIVARIN -PEN 1432UI / 0.25ml solution for injection
Indicated for: prevention and treatment of thromboembolism
Route of administration: injectable
Substance: reviparin (anticoagulant)
ATC: B01AB08 (Blood and blood forming organs | Antithrombotic agents | Heparin group)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Reviparin is an anticoagulant from the low molecular weight heparin class, used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting coagulation factors, reducing blood clot formation.
The medication is administered subcutaneously, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and undergo regular blood tests to monitor coagulation.
Patients should be aware of potential side effects, such as bleeding, bruising, or injection site reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include bleeding, bruising, and injection site reactions. In rare cases, severe reactions such as heparin-induced thrombocytopenia or major bleeding may occur. Patients should be informed of these risks before use.
General data about CLIVARIN -PEN 1432UI / 0.25ml
- Substance: reviparin
- Date of latest medicines list: 01-07-2013
- Product code: W12807001
- Concentration: 1432UI / 0.25ml
- Pharmaceutical form: solution for injection
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for reviparin
- 1432UI/0.25ml
- 3436UI/0.6ml
- 5726UI/ml